Probability of subsequent major cytogenetic response by 15 mo given no cytogenetic response in earlier months
Month of no response . | No. of patients . | Probability of subsequent MCR by 15 mo, % . | 95% CI, % . |
---|---|---|---|
Ph+ more than 65% | |||
0 | 134 | 51 | 42, 61 |
3 | 84 | 35 | 23, 47 |
6 | 57 | 24 | 10, 39 |
9 | 21 | 24 | 4, 45 |
12 | 12 | 10 | 0, 29 |
Ph+ more than 95% | |||
0 | 122 | 48 | 38, 59 |
3 | 68 | 28 | 15, 41 |
6 | 37 | 17 | 1, 33 |
9 | 15 | 10 | 0, 29 |
12 | 10 | 0 | 0, 0 |
Month of no response . | No. of patients . | Probability of subsequent MCR by 15 mo, % . | 95% CI, % . |
---|---|---|---|
Ph+ more than 65% | |||
0 | 134 | 51 | 42, 61 |
3 | 84 | 35 | 23, 47 |
6 | 57 | 24 | 10, 39 |
9 | 21 | 24 | 4, 45 |
12 | 12 | 10 | 0, 29 |
Ph+ more than 95% | |||
0 | 122 | 48 | 38, 59 |
3 | 68 | 28 | 15, 41 |
6 | 37 | 17 | 1, 33 |
9 | 15 | 10 | 0, 29 |
12 | 10 | 0 | 0, 0 |
The number of patients indicates those who had more than 65% Ph+ or more than 95% Ph+ at all times prior to or including the month indicated. For example, 134 patients had more than 65% Ph+ at baseline (month = 0) and 57 patients had consistently more than 65% Ph+ prior to or at 6 months (ie, month = 0, 3, or 6). A total of 122 patients had more than 95% Ph+ at baseline (month = 0) and 37 patients had consistently more than 95% Ph+ prior to or at 6 months (ie, month = 0, 3, or 6). MCR indicates major cytogenetic response.